Delivery Order SPE2DE24D0013-SPE2D625F2JNK
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $5,520 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order, designated XPRSTREPA-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The contract represents a procurement of molecular diagnostic solutions from Cepheid, a specialized manufacturer of advanced...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $1,104 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award builds upon Cepheid's extensive track record providing molecular diagnostic...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $13,600 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. Issued on August 14, 2025, with an ultimate completion date of August 21, 2025, this delivery order (XPRS4PLEX-10) carries no set-aside designation and represents a short-term procurement under one of Cepheid's existing indefinite delivery vehicle contracts. The place of performance is Sunnyvale,...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $9,319 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 1, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The delivery order is issued under one of Cepheid's existing Indefinite Delivery Vehicle...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $4,568.25 to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for...
- The Defense Logistics Agency awarded a delivery order to Cepheid Inc. valued at $26,312.70 under a firm fixed-price contract with an ultimate completion date of August 12, 2025. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. This delivery order carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a...
- The U.S. Defense Logistics Agency (under the Medical Supply Chain division) awarded a firm fixed-price delivery order valued at $8,820.00 to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California. The delivery order, issued on August 21, 2025, with an ultimate completion date of August 28, 2025, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. This award represents a continuation of Cepheid's ongoing...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2JNKDelivery Order
The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $47,924 firm fixed-price delivery order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California. This delivery order, designated XPRSTREPA-10, carries an ultimate completion date of September 9, 2025, and represents work to be performed at Cepheid's Sunnyvale facility. The contract was awarded without set-aside designation on September 2, 2025, reflecting open competition in the federal molecular diagnostics marketplace. This delivery order represents a continuation of Cepheid's substantial partnership with the Department of Veterans Affairs and Defense Logistics Agency in providing advanced diagnostic testing capabilities. Cepheid specializes in GeneXpert diagnostic systems and associated molecular reagents for detecting infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other clinically significant pathogens. The company maintains two significant indefinite delivery vehicles with the VA valued collectively at approximately $35.3 million through 2030, positioning it as a key supplier of diagnostic equipment and testing services across the federal healthcare system. This specific delivery order aligns with the company's core mission of delivering reliable molecular diagnostic solutions to federal agencies supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.9k | 9/2/25 |